78.10
전일 마감가:
$78.09
열려 있는:
$77.9
하루 거래량:
1.43M
Relative Volume:
0.17
시가총액:
$100.07B
수익:
$402.11B
순이익/손실:
$1.73B
주가수익비율:
56.45
EPS:
1.3835
순현금흐름:
$7.81B
1주 성능:
-0.19%
1개월 성능:
+2.55%
6개월 성능:
-1.99%
1년 성능:
+12.83%
CVS헬스 Stock (CVS) Company Profile
명칭
Cvs Health Corp
전화
(401) 765-1500
주소
ONE CVS DR., WOONSOCKET
Compare CVS vs UNH, CI, ELV, HUM
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
|
CVS
Cvs Health Corp
|
78.08 | 101.67B | 402.11B | 1.73B | 7.81B | 1.3835 |
|
UNH
Unitedhealth Group Inc
|
317.21 | 276.23B | 447.57B | 12.81B | 16.08B | 13.19 |
|
CI
Cigna Group
|
274.35 | 71.52B | 274.88B | 6.29B | 8.39B | 22.19 |
|
ELV
Elevance Health Inc
|
317.84 | 68.43B | 199.13B | 5.66B | 3.17B | 25.11 |
|
HUM
Humana Inc
|
198.31 | 23.07B | 129.66B | 1.20B | 375.00M | 9.8083 |
CVS헬스 Stock (CVS) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2026-03-12 | 업그레이드 | Bernstein | Mkt Perform → Outperform |
| 2025-10-14 | 개시 | Goldman | Buy |
| 2025-08-18 | 업그레이드 | UBS | Neutral → Buy |
| 2025-08-14 | 업그레이드 | Robert W. Baird | Neutral → Outperform |
| 2025-02-13 | 업그레이드 | Leerink Partners | Market Perform → Outperform |
| 2025-02-12 | 업그레이드 | Cantor Fitzgerald | Neutral → Overweight |
| 2025-01-30 | 업그레이드 | Edward Jones | Hold → Buy |
| 2024-12-03 | 업그레이드 | Deutsche Bank | Hold → Buy |
| 2024-11-18 | 업그레이드 | Wells Fargo | Equal Weight → Overweight |
| 2024-10-10 | 업그레이드 | Barclays | Equal Weight → Overweight |
| 2024-10-04 | 업그레이드 | TD Cowen | Hold → Buy |
| 2024-05-30 | 개시 | Robert W. Baird | Neutral |
| 2024-05-07 | 다운그레이드 | TD Cowen | Buy → Hold |
| 2024-05-02 | 다운그레이드 | UBS | Buy → Neutral |
| 2024-05-01 | 다운그레이드 | Cantor Fitzgerald | Overweight → Neutral |
| 2024-05-01 | 다운그레이드 | Leerink Partners | Outperform → Market Perform |
| 2024-03-06 | 개시 | Barclays | Equal Weight |
| 2024-02-26 | 개시 | Leerink Partners | Outperform |
| 2023-12-22 | 개시 | HSBC Securities | Buy |
| 2023-09-19 | 업그레이드 | Evercore ISI | In-line → Outperform |
| 2023-09-12 | 업그레이드 | Wolfe Research | Peer Perform → Outperform |
| 2023-08-18 | 다운그레이드 | Edward Jones | Buy → Hold |
| 2023-05-26 | 개시 | Piper Sandler | Overweight |
| 2023-04-21 | 개시 | Cantor Fitzgerald | Overweight |
| 2023-01-03 | 다운그레이드 | Evercore ISI | Outperform → In-line |
| 2022-11-23 | 재개 | Morgan Stanley | Overweight |
| 2022-06-17 | 개시 | Loop Capital | Buy |
| 2022-05-27 | 다운그레이드 | Bernstein | Outperform → Mkt Perform |
| 2022-03-29 | 다운그레이드 | Deutsche Bank | Buy → Hold |
| 2022-02-11 | 다운그레이드 | Raymond James | Strong Buy → Outperform |
| 2021-12-14 | 개시 | Goldman | Buy |
| 2021-12-01 | 개시 | Seaport Research Partners | Buy |
| 2021-05-19 | 개시 | Wells Fargo | Equal Weight |
| 2021-03-17 | 다운그레이드 | Guggenheim | Buy → Neutral |
| 2021-01-08 | 업그레이드 | Jefferies | Hold → Buy |
| 2020-09-17 | 개시 | Piper Sandler | Overweight |
| 2020-07-01 | 개시 | SVB Leerink | Mkt Perform |
| 2020-05-14 | 업그레이드 | Credit Suisse | Neutral → Outperform |
| 2019-09-27 | 재개 | RBC Capital Mkts | Outperform |
| 2019-09-12 | 개시 | Deutsche Bank | Buy |
| 2019-06-05 | 업그레이드 | Standpoint Research | Hold → Buy |
| 2019-04-29 | 다운그레이드 | Credit Suisse | Outperform → Neutral |
| 2019-04-18 | 개시 | Guggenheim | Buy |
| 2019-04-15 | 다운그레이드 | Oppenheimer | Outperform → Perform |
| 2019-04-10 | 재확인 | BofA/Merrill | Buy |
| 2019-03-13 | 개시 | Bernstein | Outperform |
| 2019-02-20 | 다운그레이드 | Wells Fargo | Outperform → Market Perform |
| 2019-01-17 | 개시 | UBS | Buy |
| 2018-12-18 | 개시 | Barclays | Overweight |
| 2018-11-29 | 재개 | Goldman | Neutral |
| 2018-11-28 | 개시 | Evercore ISI | Outperform |
| 2018-10-26 | 재개 | Wolfe Research | Peer Perform |
| 2018-07-09 | 업그레이드 | Citigroup | Neutral → Buy |
| 2018-02-27 | 재개 | BofA/Merrill | Buy |
| 2018-02-13 | 재확인 | Citigroup | Neutral |
모두보기
CVS헬스 주식(CVS)의 최신 뉴스
Patton Fund Management Inc. Boosts Holdings in CVS Health Corporation $CVS - MarketBeat
Third View Private Wealth LLC Takes Position in CVS Health Corporation $CVS - MarketBeat
CVS Health Corp. stock (US1266501006): Is healthcare integration still delivering value for investor - AD HOC NEWS
CVS Health Corporation (NYSE:CVS) Given Average Recommendation of "Moderate Buy" by Analysts - MarketBeat
CVS Health Just Got a $13 Billion Reprieve. Here's Why the Stock Could Keep Climbing. - AOL.com
CVS Health Just Got a $13 Billion Reprieve. Here's Why the Stock Could Keep Climbing. - The Motley Fool
CVS Health Corp. stock underperforms Monday when compared to competitors - MarketWatch
Should You Buy CVS Health Stock Before May 6? - The Motley Fool
Sumitomo Mitsui Trust Group Inc. Cuts Stake in CVS Health Corporation - National Today
2 Recession Resistant Dividend Stocks to Buy Now While They're Still Cheap - AOL.com
Sumitomo Mitsui Trust Group Inc. Cuts Holdings in CVS Health Corporation $CVS - MarketBeat
Huge News for CVS Stock Investors - The Globe and Mail
CVS Health Corporation (CVS): Legal Clarity and Core Strengths Support the Bull Case - Insider Monkey
Robeco Institutional Asset Management B.V. Raises Position in CVS Health Corporation $CVS - MarketBeat
Burney Co. Trims Stake in CVS Health - National Today
Carnegie Investment Counsel Purchases New Shares in CVS Health Corporation $CVS - MarketBeat
Trump Administration Walks Back Key Claims in New York Health Fraud Case: ReportCVS Health (NYSE:CVS) - Benzinga
Coerente Capital Management Trims CVS Health Stock Position - National Today
Cantor Fitzgerald Investment Advisors L.P. Has $29.68 Million Stock Holdings in CVS Health Corporation $CVS - MarketBeat
Coerente Capital Management Trims Stock Position in CVS Health Corporation $CVS - MarketBeat
CVS Health Corporation $CVS Shares Sold by Factory Mutual Insurance Co. - MarketBeat
CVS Stock Quote Price and Forecast - CNN
CVS Health Tops Daily Volume Chart as Medicare Boost and Institutional Buying Surge Past $540 Million - Bitget
CVS Health Corp. stock (US1266501006): Is its pharmacy-retail model strong enough to unlock new upsi - AD HOC NEWS
How CVS Health Supports Better Heart Health - ACCESS Newswire
Douglas Lane & Associates LLC Cuts Holdings in CVS Health Corporation $CVS - MarketBeat
Flagship Capital Management Inc. Invests $2.16 Million in CVS Health Corporation $CVS - MarketBeat
Jim Cramer Says “CVS Is Real” - Insider Monkey
CVS Health, US Seek Tax-Refund Suit Stay Pending Deal Approval - Bloomberg Law News
Aetna Better Health® of Virginia opens new community resource center in Roanoke - CVS Health
Cantor Fitzgerald reiterates CVS Health stock Overweight rating at $95 - Investing.com
OFI Invest Asset Management Takes Position in CVS Health Corporation $CVS - MarketBeat
HIV, AIDS Patients End Disability Bias Suit With CVS - Law360
CVS Health Corp. Stock Hits Day High with Strong 6.74% Surge - Markets Mojo
CVS Health Corporation $CVS Shares Sold by Yousif Capital Management LLC - MarketBeat
Mail Order Pharmacy Market to Get an Explosive Growth | CVS Health - openPR.com
Aetna Provider Survey Reveals Optimism and Opportunities to Simplify Health Care - CVS Health
Health insurers pare back some prior-approval requirements - Crain's Chicago Business
CVS Stock Rises After CMS Medicare Advantage Update - Sahm
US Health Insurers Pare Back Some Prior-Approval Requirements - Bloomberg.com
Alignment Healthcare, Centene, CVS Health, Elevance Health, and Clover Health Stocks Trade Up, What You Need To Know - Yahoo Finance
Health insurers rise after US lifts 2027 Medicare Advantage payment rates - Reuters
Washington Blinked and Health Insurers Made $13 Billion - Yahoo Finance
CVS Health (NYSE:CVS) Shares Gap UpTime to Buy? - MarketBeat
CVS Health Stock Surges 7% on Positive Medicare Outlook as Turnaround Gains Momentum - International Business Times Australia
UnitedHealth, Humana, CVS Jump As CMS Boosts Medicare Payments - Benzinga
UnitedHealth, Alignment Healthcare, Humana And Other Big Stocks Moving Higher On Tuesday - Benzinga
Cantor Fitzgerald reiterates CVS Health stock rating on MA margins - Investing.com
Inlet Private Wealth Reduces Stake in CVS Health - National Today
Daytona Street Capital LLC Invests $2.69 Million in CVS Health Corporation $CVS - MarketBeat
Trump Administration Finalizes 2.48% Medicare Advantage Payment Hike For 2027, Sending Insurer Stocks Surging - Benzinga
CVS헬스 (CVS) 재무 분석
매출
순이익
현금흐름
주당 순 이익
자본화:
|
볼륨(24시간):